CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Neutrophilic leucocytosis as a presenting sign of primary gastric Hodgkin's lymphoma.
Neutrophilic leucocytosis as a presenting sign of primary gastric Hodgkin's lymphoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
一名60多岁男性患者因不明原因的中性粒细胞增多症入院。进一步诊断检查发现一个较大的胃息肉,伴有部分幽门梗阻。活检显示大量中性粒细胞围绕在类似Reed-Sternberg细胞的非典型细胞周围。通过免疫组织化学检查,确诊为胃霍奇金淋巴瘤。根据其疾病分期和高心脏风险,患者开始接受GVP(吉西他滨、长春瑞滨和泼尼松)方案治疗。在获得部分缓解后,他出现疾病进展并复发,伴有肝脏受累,提示为难治性复发疾病。因此,他开始接受纳武利尤单抗治疗,鉴于其特定的肿瘤微环境,这是最合适的选择。鉴于此,我们建议深入了解每位患者的肿瘤微环境,以指导有效的治疗策略。这在先进免疫疗法时代尤为重要,例如程序性死亡-1和程序性死亡配体-1抑制剂以及CAR-T 细胞疗法。
A male patient in his 60s was admitted due to unexplained neutrophilic leucocytosis.
Further diagnostic workup revealed a large gastric polyp with partial pyloric obstruction. Biopsy revealed numerous neutrophils surrounding atypical cells resembling Reed-Sternberg cells. The diagnosis of gastric Hodgkin's lymphoma was confirmed through immunohistochemistry. According to his disease stage and high cardiac risk, he was started on the GVP (gemcitabine, vinorelbine and prednisone) protocol. Following a partial response, he experienced disease progression and relapse with hepatic involvement, indicating relapsed and refractory disease.
Therefore, he was started on nivolumab, which was the most suitable option, given his specific tumour microenvironment. In the light of this, we recommend a deeper understanding of the tumour microenvironment for each patient to guide effective treatment strategies. This is especially important in the era of advanced immunotherapies, such as programmed death-1 and programmed death-ligand 1 inhibitors and chimeric antigen receptor T-cell therapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。